Cargando…

The Differences in Ultrasound and Clinicopathological Features between Basal-Like and Normal-Like Subtypes of Triple Negative Breast Cancer

PURPOSE: The aim of this study was to identify the ultrasound features and clinicopathological characteristics of basal-like subtype of triple negative breast cancers (TNBCs). MATERIALS AND METHODS: This study was approved by the ethical board of the Second Affiliated Hospital of Harbin Medical Univ...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Ziyao, Ren, Min, Tian, Jiawei, Jiang, Shuangquan, Liu, Yujie, Zhang, Lei, Wang, Zhenzhen, Song, Qianqian, Liu, Chong, Wu, Tong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4348341/ https://www.ncbi.nlm.nih.gov/pubmed/25734578 http://dx.doi.org/10.1371/journal.pone.0114820

Ejemplares similares

Mammography and ultrasound effective features in differentiating basal-like and normal-like subtypes of triple negative breast cancer
por: Zeng, Zeng, et al.
Publicado: (2017)

Triple-negative breast cancer with brain metastases: a comparison between basal-like and non-basal-like biological subtypes
por: Niwińska, Anna, et al.
Publicado: (2011)

Feline mammary basal-like adenocarcinomas: a potential model for human triple-negative breast cancer (TNBC) with basal-like subtype
por: Wiese, David A, et al.
Publicado: (2013)

Are Basal-Like and Non-Basal-Like Triple-Negative Breast Cancers Really Different?
por: Dogra, Atika, et al.
Publicado: (2020)

Comparative proteomic and clinicopathological analysis of breast adenoid cystic carcinoma and basal-like triple-negative breast cancer
por: Yao, Qian, et al.
Publicado: (2022)

Identification of Personalized Chemoresistance Genes in Subtypes of Basal-Like Breast Cancer Based on Functional Differences Using Pathway Analysis
por: Wu, Tong, et al.
Publicado: (2015)

Are triple-negative tumours and basal-like breast cancer synonymous?
por: Rakha, Emad A, et al.
Publicado: (2007)

Cancer stem cells are prevalent in the basal-like 2 and mesenchymal triple-negative breast cancer subtypes in vitro
por: Olsson, Maxim, et al.
Publicado: (2023)

Yuanhuacine Is a Potent and Selective Inhibitor of the Basal-Like 2 Subtype of Triple Negative Breast Cancer with Immunogenic Potential
por: Fermaintt, Charles S., et al.
Publicado: (2021)

The Epigenetics of Triple-Negative and Basal-Like Breast Cancer: Current Knowledge
por: Temian, Daiana Cosmina, et al.
Publicado: (2018)

Are triple-negative tumours and basal-like breast cancer synonymous? Authors' response
por: Kreike, Bas, et al.
Publicado: (2007)

p16 expression correlates with basal-like triple-negative breast carcinoma
por: Abou-Bakr, Amany A, et al.
Publicado: (2013)

Triple-negative, basal-like, and quintuple-negative breast cancers: better prediction model for survival
por: Choi, Yoon-La, et al.
Publicado: (2010)

Ultrasound and Clinicopathological Characteristics of Triple Receptor-Negative Breast Cancers
por: Choi, Yoon Jung, et al.
Publicado: (2011)

Gene expression profiling and histopathological characterization of triple-negative/basal-like breast carcinomas
por: Kreike, Bas, et al.
Publicado: (2007)

A clinically relevant gene signature in triple negative and basal-like breast cancer
por: Rody, Achim, et al.
Publicado: (2011)

Calpain system protein expression in basal-like and triple-negative invasive breast cancer
por: Storr, S. J., et al.
Publicado: (2012)

Modulatory Role of microRNAs in Triple Negative Breast Cancer with Basal-Like Phenotype
por: Angius, Andrea, et al.
Publicado: (2020)

Correction: triple-negative, basal-like, and quintuple-negative breast cancers: better prediction model for survival
por: Choi, Yoon-La, et al.
Publicado: (2011)

Caveolin 1 and Caveolin 2 are associated with breast cancer basal-like and triple-negative immunophenotype
por: Elsheikh, S E, et al.
Publicado: (2008)

Screening potential immune signatures for early-stage basal-like/triple-negative breast cancer
por: Wu, Min, et al.
Publicado: (2022)

Hippo-TAZ signaling is the master regulator of the onset of triple-negative basal-like breast cancers
por: Soyama, Hirotoshi, et al.
Publicado: (2022)

Lymph node status in different molecular subtype of breast cancer: triple negative tumours are more likely lymph node negative
por: Liu, Ning, et al.
Publicado: (2017)

The Clinicopathological Features and Survival Outcomes of Different Histological Subtypes in Triple-negative Breast Cancer
por: Liao, Hong-Ye, et al.
Publicado: (2018)

miRNA-135b Contributes to Triple Negative Breast Cancer Molecular Heterogeneity: Different Expression Profile in Basal-like Versus non-Basal-like Phenotypes
por: Uva, Paolo, et al.
Publicado: (2018)

Oxidative stress and counteracting mechanisms in hormone receptor positive, triple-negative and basal-like breast carcinomas
por: Karihtala, Peeter, et al.
Publicado: (2011)

LIPG signaling promotes tumor initiation and metastasis of human basal-like triple-negative breast cancer
por: Lo, Pang-Kuo, et al.
Publicado: (2018)

Overexpression of Raf-1 in basal-like carcinoma of the breast: correlation with clinicopathology and prognosis
por: Wu, Ping, et al.
Publicado: (2014)

Inhibition of LIPG phospholipase activity suppresses tumor formation of human basal-like triple-negative breast cancer
por: Lo, Pang-Kuo, et al.
Publicado: (2020)

Identification of key genes unique to the luminal a and basal-like breast cancer subtypes via bioinformatic analysis
por: Jia, Rong, et al.
Publicado: (2020)

Inhibition of SHP2 in basal-like and triple-negative breast cells induces basal-to-luminal transition, hormone dependency, and sensitivity to anti-hormone treatment
por: Zhao, Hua, et al.
Publicado: (2015)

Preliminary characterization of IL32 in basal-like/triple negative compared to other types of breast cell lines and tissues
por: Player, Audrey, et al.
Publicado: (2014)

Mesothelin Expression in Triple Negative Breast Carcinomas Correlates Significantly with Basal-Like Phenotype, Distant Metastases and Decreased Survival
por: Tozbikian, Gary, et al.
Publicado: (2014)

Targeting EphA2 impairs cell cycle progression and growth of basal-like/triple-negative breast cancers
por: Song, W, et al.
Publicado: (2017)

Comparison of molecular profile in triple-negative inflammatory and non-inflammatory breast cancer not of mesenchymal stem-like subtype
por: Funakoshi, Yohei, et al.
Publicado: (2019)

Comparison of Clinicopathological Features and Prognosis in Triple-Negative and Non-Triple Negative Breast Cancer
por: Qiu, Jingdan, et al.
Publicado: (2016)

Identifying ultrasound and clinical features of breast cancer molecular subtypes by ensemble decision
por: Zhang, Lei, et al.
Publicado: (2015)

Nuclear CSPP1 expression defined subtypes of basal-like breast cancer
por: Sternemalm, J, et al.
Publicado: (2014)

Comprehensive Analysis of LincRNAs in Classical and Basal-Like Subtypes of Pancreatic Cancer
por: Glaß, Markus, et al.
Publicado: (2020)

Tumor microbiome contributes to an aggressive phenotype in the basal-like subtype of pancreatic cancer
por: Guo, Wei, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_751nlcppo18oa6t472ikierkjp